Maca has been reported to alleviate male menopause symptoms in humans and experimental animals; however, its mechanism of action in improving male menopause has not been clearly identified. This study aimed to investigate the mechanism of action of gelatinized maca in improving male menopause by analyzing serum testosterone, testicular androgen receptor (AR) expression, and testicular oxidation-antioxidation balance. Gelatinized maca was administered orally to aged male C57BL/6 mice at three doses (500, 1,000, and 1,500 mg/kg/day) for 28 consecutive days. Serum biochemical analysis showed an increase in serum hydroxysteroid 17-beta-dehydrogenase 13 (HSD17β13) concentration at 1,500 mg/kg/day and a decrease in serum sex hormone-binding globulin (SHBG) concentration at ≥ 1,000 mg/kg/day. Gelatinized maca administration also resulted in the increased expression levels of testicular AR and cyclic adenosine monophosphate (cAMP) response element binding protein (CREB) at 1,500 mg/kg/day. Oxidative stress analysis showed an increase in testicular superoxide dismutase and glutathione reductase activities and a decrease in testicular malondialdehyde at 1,500 mg/kg/day. In conclusion, gelatinized maca administration to aged male mice increased HSD17β13, AR and CREB expression, and antioxidant capacity and decreased serum SHBG. The results of the present study suggest that gelatinized maca may be a useful substance that can help alleviate male menopause symptoms.

Probiotics, enzymes, organic acids, oligosaccharides, antioxidants, and other functional materials are actively being explored as alternatives to antibiotics. Probiotics include live beneficial microorganisms that colonize the intestinal tract and competitively inhibit attachment and growth of harmful microbes. Probiotics also increase feed efficiency by assisting in nutrient absorption and digestion. The current study was conducted in order to evaluate the effect of a new probiotic, CS-A, as a dietary supplement of a fermented product on growth performance, feed intake, and feed conversion efficiency in broiler chickens, and to evaluate its value as an alternative for antibiotics used as a feed additive. Antibacterial and anti-inflammatory effects of CS-A were investigated in vitro and the in vivo effects of a constant concentration of supplemented CS-A on growth rate and feed efficiency were evaluated. In addition, the safety of CS-A was assessed by examination of common symptoms and mortality. Determination of minimal inhibitory concentration revealed an excellent antibacterial effect of CS-A. Cytotoxicity was low and anti-inflammatory effects were achieved at the effective concentration of CS-A. Supplementation with 0.1% CS-A resulted in a feed efficiency score of 1.84 in broilers, compared to 2.00 in the control group. There were no adverse clinical findings, necropsy findings, hematology, and altered serum biochemistry parameters, and no mortality. Thus, it is concluded that CS-A is safe and effective as a feed additive.